Convergence Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $279K | Sell |
770
-115
| -13% | -$39.4K | 0.03% | 221 |
|
|
2026
Q1 | $311K | Sell |
885
-35
| -4% | -$12.5K | 0.05% | 219 |
|
|
2025
Q4 | $301K | Sell |
920
-28
| -3% | -$8.88K | 0.06% | 220 |
|
|
2025
Q3 | $267K | Buy |
948
+1
| +0.1% | +$290 | 0.06% | 228 |
|
|
2025
Q2 | $265K | Sell |
947
-52
| -5% | -$14.7K | 0.07% | 214 |
|
|
2025
Q1 | $311K | Sell |
999
-248
| -20% | -$73.2K | 0.09% | 212 |
|
|
2024
Q4 | $325K | Sell |
1,247
-1,431
| -53% | -$425K | 0.07% | 207 |
|
|
2024
Q3 | $863K | Sell |
2,678
-8,683
| -76% | -$2.84M | 0.23% | 140 |
|
|
2024
Q2 | $3.55M | Sell |
11,361
-718
| -6% | -$211K | 1.04% | 20 |
|
|
2024
Q1 | $3.43M | Buy |
12,079
+289
| +2% | +$84.6K | 1.32% | 18 |
|
|
2023
Q4 | $3.4M | Sell |
11,790
-313
| -3% | -$85.3K | 1.77% | 10 |
|
|
2023
Q3 | $3.25M | Sell |
12,103
-150
| -1% | -$37.4K | 1.92% | 9 |
|
|
2023
Q2 | $2.72M | Sell |
12,253
-1,446
| -11% | -$336K | 1.56% | 12 |
|
|
2023
Q1 | $3.31M | Sell |
13,699
-76
| -0.6% | -$18.7K | 1.95% | 8 |
|
|
2022
Q4 | $3.62M | Sell |
13,775
-533
| -4% | -$143K | 2.14% | 6 |
|
|
2022
Q3 | $3.23M | Buy |
14,308
+4,622
| +48% | +$1.12M | 2.11% | 5 |
|
|
2022
Q2 | $2.36M | Sell |
9,686
-370
| -4% | -$90.7K | 1.43% | 11 |
|
|
2022
Q1 | $2.43M | Buy |
10,056
+594
| +6% | +$136K | 1.25% | 17 |
|
|
2021
Q4 | $2.13M | Sell |
9,462
-81
| -0.8% | -$17.1K | 1.08% | 21 |
|
|
2021
Q3 | $2.03M | Sell |
9,543
-3,142
| -25% | -$723K | 1.09% | 23 |
|
|
2021
Q2 | $3.09M | Buy |
12,685
+41
| +0.3% | +$10.1K | 1.33% | 13 |
|
|
2021
Q1 | $3.15M | Sell |
12,644
-633
| -5% | -$151K | 1.44% | 12 |
|
|
2020
Q4 | $3.05M | Sell |
13,277
-5,158
| -28% | -$1.19M | 1.54% | 10 |
|
|
2020
Q3 | $4.68M | Sell |
18,435
-3,563
| -16% | -$883K | 1.63% | 7 |
|
|
2020
Q2 | $5.19M | Buy |
21,998
+389
| +2% | +$88.8K | 1.78% | 5 |
|
|
2020
Q1 | $4.38M | Buy |
21,609
+751
| +4% | +$164K | 1.92% | 6 |
|
|
2019
Q4 | $5.03M | Sell |
20,858
-628
| -3% | -$138K | 1.43% | 7 |
|
|
2019
Q3 | $4.16M | Sell |
21,486
-5,590
| -21% | -$1.07M | 1.16% | 16 |
|
|
2019
Q2 | $4.99M | Sell |
27,076
-1,470
| -5% | -$263K | 1.21% | 12 |
|
|
2019
Q1 | $5.42M | Sell |
28,546
-290
| -1% | -$55.4K | 1.18% | 11 |
|
|
2018
Q4 | $5.61M | Sell |
28,836
-1,633
| -5% | -$319K | 1.29% | 10 |
|
|
2018
Q3 | $6.32M | Sell |
30,469
-18,990
| -38% | -$3.74M | 1.29% | 8 |
|
|
2018
Q2 | $9.13M | Sell |
49,459
-5,495
| -10% | -$972K | 1.27% | 8 |
|
|
2018
Q1 | $9.37M | Buy |
54,954
+7,618
| +16% | +$1.4M | 1.22% | 7 |
|
|
2017
Q4 | $8.23M | Buy |
47,336
+2,954
| +7% | +$523K | 1.11% | 10 |
|
|
2017
Q3 | $8.28M | Buy |
44,382
+10,795
| +32% | +$1.91M | 1.17% | 5 |
|
|
2017
Q2 | $5.79M | Sell |
33,587
-1,230
| -4% | -$200K | 0.85% | 13 |
|
|
2017
Q1 | $5.71M | Sell |
34,817
-1,990
| -5% | -$331K | 0.8% | 15 |
|
|
2016
Q4 | $5.38M | Sell |
36,807
-5,662
| -13% | -$852K | 0.74% | 20 |
|
|
2016
Q3 | $7.08M | Buy |
42,469
+469
| +1% | +$79.3K | 1.05% | 8 |
|
|
2016
Q2 | $6.39M | Sell |
42,000
-17,633
| -30% | -$2.74M | 0.88% | 12 |
|
|
2016
Q1 | $8.94M | Sell |
59,633
-17,535
| -23% | -$2.61M | 1.06% | 8 |
|
|
2015
Q4 | $12.5M | Buy |
77,168
+83
| +0.1% | +$13K | 1.41% | 5 |
|
|
2015
Q3 | $10.7M | Sell |
77,085
-799
| -1% | -$126K | 1.22% | 7 |
|
|
2015
Q2 | $12M | Buy |
77,884
+40,691
| +109% | +$6.52M | 1.18% | 7 |
|
|
2015
Q1 | $5.95M | Buy |
37,193
+23,946
| +181% | +$3.77M | 0.83% | 11 |
|
|
2014
Q4 | $2.11M | Buy |
+13,247
| New | +$2.06M | 0.28% | 130 |
|
Other funds holding AMGN
Convergence Investment Partners's AMGN Position: Q2 2026 in Review
Convergence Investment Partners reduced its Amgen (AMGN) stake by 13% in Q2 2026, selling an estimated $39.4K and leaving 770 shares worth $279K. The position accounts for 0.03% of the portfolio, ranked #221.
Convergence Investment Partners first reported a position in AMGN in Q4 2014 and has held it in 47 quarters since. The position peaked at $12.5M in Q4 2015. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Convergence Investment Partners held 770 shares of Amgen worth $279K as of Q2 2026.
- Convergence Investment Partners sold 115 Amgen shares in Q2 2026, an estimated $39.4K.
- Amgen made up 0.03% of Convergence Investment Partners's portfolio in Q2 2026, its #221 holding.
- Convergence Investment Partners first reported a position in Amgen in Q4 2014 and has held it in 47 quarters since.
- Convergence Investment Partners's Amgen position peaked at $12.5M in Q4 2015.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.